Cavanaugh Sarah

Avg. Two Year Performance

No purchase track record
No sale track record
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return139%133%287%0%0%
Purchase Success Rate1 of 11 of 11 of 10 of 10 of 1
Average Sale Return0%0%0%0%0%
Sale Success Rate0 of 20 of 20 of 20 of 20 of 2

AVANT Immunotherapeutics, I...

Drugs » Diagnostic Substances

SVP of Corp Affairs & Admin.:

Holdings: 1.86K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--